Hint mode is switched on Switch off
For swift navigation between sections

Domestic bonds: Bayer, 3.75% 1jul2074, EUR
DE000A11QR73

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy

Subordinated

Issue
Issuer
  • M
    -
    ***
  • S&P
    -
    ***
  • F
    -
    -
Status
Outstanding
Amount
1,500,000,000 EUR
Placement
***
Early redemption
*** (-)
Country of risk
Germany
Current coupon
***%
Price
***%
Yield / Duration
-
Corporate Actions Issuer news
Add issue to Watchlist
{{ watchlistErrorMsg }}
Adding issue to the Watchlist is not possible because there are no quotes from exchanges for it.
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Files

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Download the chart in a convenient format
More than 2,500 records have been found, please specify your request
* Data is not available within the selected subscription
Latest data on
Quotes from market participants are indicative

Stock exchange and OTC quotes

Issue information

Profile
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection ...
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
  • Issuer
    Go to the issuer page
    Bayer
  • Full issuer name
    Bayer AG
  • Sector
    corporate
  • Industry
    Chemical and petrochemical industry
Volume
  • Amount
    1,500,000,000 EUR
  • Outstanding face value amount
    1,500,000,000 EUR
  • USD equivalent
    1,774,065,000 USD
Nominal
  • Nominal
    1,000 EUR
  • Outstanding face value
    *** EUR
  • Par amount, integral multiple
    *** EUR

Cash flow parameters

  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Delay days
    *** days
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Early redemption terms

***

DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Placement

  • Placement method
    Open subscription
  • Order book
    *** (***) - *** (***)
  • Coupon (Yield) Guidance
    ***% - ***% (*** - ***%)
  • Issuer rating on issue date (M/S&P/F)
    - / *** / -
  • Placement
    *** - ***
  • Initial issue price (yield)
    (***%)
  • Bids
    *** EUR
  • Number of bids
    ***
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
  • The purpose of placing
    The net proceeds of the issuance of the Notes, amounting to approximately EUR 3,233,750,000, will be used to finance in part the acquisition of the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA. In the event that the aforementioned transaction is not consummated, the proceeds of the issuance of the Notes may be used for the Issuer's general corporate purposes, which may include the financing of other merger and acquisition activities, if any.
  • Listing
    ***
Participants
  • Bookrunner
    ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***, ***
  • Paying agent
    ***

Conversion and exchange

  • Convertion date
    ***
  • Initial premium
    ***%
  • Convertible until
    ***
  • Lock-up
    *** days
  • Conversion terms

Additional information

***

Latest issues

Stocks

Identifiers

  • Registration
    ***
  • Date of program registration
    ***
  • ISIN
    DE000A11QR73
  • CUSIP
    ***
  • CUSIP 144A
    ***
  • Common Code
    108314168
  • CFI
    DBVUGB
  • FIGI
    BBG006Q4DFH3
  • WKN
    A11QR7
  • SEDOL
    BNLPXY9
  • Ticker
    BAYNGR V3.75 07/01/74
  • Type of security by CBR
    ***

Ratings

Issue ratings
Issuer ratings

Bond classification

  • Coupon bonds
  • Bearer
  • Subordinated
  • Amortization
  • CDO
  • Convertible
  • Dual currency bonds
  • For qualified investors
  • Foreign bonds
  • Green bonds
  • Indexed
  • Supranational bond issues
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Sukuk
  • Trace-eligible

Restructuring

***

***

Holders